FR2163717A1 - - Google Patents

Info

Publication number
FR2163717A1
FR2163717A1 FR7244857A FR7244857A FR2163717A1 FR 2163717 A1 FR2163717 A1 FR 2163717A1 FR 7244857 A FR7244857 A FR 7244857A FR 7244857 A FR7244857 A FR 7244857A FR 2163717 A1 FR2163717 A1 FR 2163717A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7244857A
Other versions
FR2163717B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP46102854A external-priority patent/JPS5820956B2/ja
Priority claimed from JP46102855A external-priority patent/JPS5812273B2/ja
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of FR2163717A1 publication Critical patent/FR2163717A1/fr
Application granted granted Critical
Publication of FR2163717B1 publication Critical patent/FR2163717B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
FR7244857A 1971-12-18 1972-12-15 Expired FR2163717B1 (fr)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP46102854A JPS5820956B2 (ja) 1971-12-18 1971-12-18 シンキナル アセチレンケトンユウドウタイ ノ シンキセイゾウホウ
JP46102855A JPS5812273B2 (ja) 1971-12-18 1971-12-18 シンキ アセチレンアルコ−ルユウドウタイ ノ シンキセイゾウホウ
JP1616972A JPS5544749B2 (fr) 1971-12-18 1972-02-15
JP1675272A JPS5535390B2 (fr) 1971-12-18 1972-02-17
JP47043125A JPS491530A (fr) 1971-12-18 1972-04-28
JP47065208A JPS4924932A (fr) 1971-12-18 1972-06-28
JP47070265A JPS5820957B2 (ja) 1971-12-18 1972-07-12 シンキ ナル ブテノ−ルアミンユウドウタイ ノ シンキセイゾウホウ
JP47070266A JPS5839826B2 (ja) 1971-12-18 1972-07-12 シンキナルオレフイニツクアミノケトンユウドウタイ ノ シンキセイゾウホウ
JP47095720A JPS4961130A (fr) 1971-12-18 1972-09-22

Publications (2)

Publication Number Publication Date
FR2163717A1 true FR2163717A1 (fr) 1973-07-27
FR2163717B1 FR2163717B1 (fr) 1977-07-15

Family

ID=27576674

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7244857A Expired FR2163717B1 (fr) 1971-12-18 1972-12-15

Country Status (9)

Country Link
JP (7) JPS5544749B2 (fr)
AU (1) AU470861B2 (fr)
BE (1) BE792906A (fr)
CH (2) CH589661A5 (fr)
FI (1) FI57933C (fr)
FR (1) FR2163717B1 (fr)
GB (1) GB1407706A (fr)
NL (1) NL7217236A (fr)
SE (1) SE399707B (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2280378A1 (fr) * 1974-07-29 1976-02-27 Sumitomo Chemical Co Derives de piperidinobutyrophenone
FR2414495A1 (fr) * 1978-01-13 1979-08-10 Sumitomo Chemical Co Procede de production de composes cetoniques conjugues, nouveaux produits ainsi obtenus et leur utilisation, notamment pour la prevention de la thrombose intravasculaire
EP0169400A1 (fr) * 1984-06-27 1986-01-29 Ss Pharmaceutical Co., Ltd. Dérivés aminométhylés, procédé pour leur préparation et inhibiteurs d'agrégation de plaquettes les contenant
EP0520032A1 (fr) * 1990-03-16 1992-12-30 Beth Israel Hospital Association Utilisation de spiperone comme agent immunosuppresseur et anti-inflammatoire
US5244902A (en) * 1989-08-21 1993-09-14 Beth Israel Hospital Association Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5693645A (en) * 1992-12-23 1997-12-02 Beth Israel Deaconess Medical Center, Inc. Use of spiperone or spiperone derivatives as immunosuppressant agents
US5703088A (en) * 1989-08-21 1997-12-30 Beth Israel Deaconess Medical Center, Inc. Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50140451A (fr) * 1974-04-16 1975-11-11
JPS5283863U (fr) * 1975-12-13 1977-06-22
JPS5324020A (en) * 1976-08-14 1978-03-06 Kumiai Chem Ind Co Ltd Composition for herbicide
JPS5498755A (en) * 1978-01-13 1979-08-03 Sumitomo Chem Co Ltd Novel butenophenone derivative
JPS55116000U (fr) * 1979-02-10 1980-08-15
US11707027B2 (en) 2019-12-02 2023-07-25 Fork Farms Holdings, Llc Hydroponic grow assembly

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2070166A1 (fr) * 1969-10-27 1971-09-10 Sumitomo Chemical Co
FR2073326A1 (fr) * 1969-11-04 1971-10-01 Sumitomo Chemical Co

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2070166A1 (fr) * 1969-10-27 1971-09-10 Sumitomo Chemical Co
FR2073326A1 (fr) * 1969-11-04 1971-10-01 Sumitomo Chemical Co

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2280378A1 (fr) * 1974-07-29 1976-02-27 Sumitomo Chemical Co Derives de piperidinobutyrophenone
FR2414495A1 (fr) * 1978-01-13 1979-08-10 Sumitomo Chemical Co Procede de production de composes cetoniques conjugues, nouveaux produits ainsi obtenus et leur utilisation, notamment pour la prevention de la thrombose intravasculaire
EP0169400A1 (fr) * 1984-06-27 1986-01-29 Ss Pharmaceutical Co., Ltd. Dérivés aminométhylés, procédé pour leur préparation et inhibiteurs d'agrégation de plaquettes les contenant
US5244902A (en) * 1989-08-21 1993-09-14 Beth Israel Hospital Association Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5639758A (en) * 1989-08-21 1997-06-17 Beth Israel Deaconess Medical Center, Inc. Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
US5703088A (en) * 1989-08-21 1997-12-30 Beth Israel Deaconess Medical Center, Inc. Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
EP0520032A1 (fr) * 1990-03-16 1992-12-30 Beth Israel Hospital Association Utilisation de spiperone comme agent immunosuppresseur et anti-inflammatoire
EP0520032A4 (en) * 1990-03-16 1993-02-24 Beth Israel Hospital Association Use of spiperone as an immunosuppressant and anti-inflammatory agent
US5693645A (en) * 1992-12-23 1997-12-02 Beth Israel Deaconess Medical Center, Inc. Use of spiperone or spiperone derivatives as immunosuppressant agents

Also Published As

Publication number Publication date
GB1407706A (en) 1975-09-24
JPS4885569A (fr) 1973-11-13
SE399707B (sv) 1978-02-27
JPS4881854A (fr) 1973-11-01
JPS5535390B2 (fr) 1980-09-12
JPS4961130A (fr) 1974-06-13
CH593296A5 (fr) 1977-11-30
JPS4924932A (fr) 1974-03-05
AU470861B2 (en) 1974-06-20
JPS4930335A (fr) 1974-03-18
FR2163717B1 (fr) 1977-07-15
FI57933C (fi) 1980-11-10
FI57933B (fi) 1980-07-31
JPS491530A (fr) 1974-01-08
JPS5820957B2 (ja) 1983-04-26
JPS5544749B2 (fr) 1980-11-13
JPS4930336A (fr) 1974-03-18
JPS5839826B2 (ja) 1983-09-01
NL7217236A (fr) 1973-06-20
AU5023172A (en) 1974-06-20
BE792906A (fr) 1973-06-18
CH589661A5 (fr) 1977-07-15

Similar Documents

Publication Publication Date Title
FR2163717B1 (fr)
JPS4852775A (fr)
AU2691671A (fr)
AU2894671A (fr)
AU3005371A (fr)
AU2952271A (fr)
AU2485671A (fr)
AU2941471A (fr)
AU2742671A (fr)
AU3038671A (fr)
AU2755871A (fr)
AU2726271A (fr)
AU2706571A (fr)
AU3025871A (fr)
AU2724971A (fr)
AU2486471A (fr)
AU2963771A (fr)
AU2740271A (fr)
AU2854371A (fr)
AU2940971A (fr)
AU2938071A (fr)
AU2930871A (fr)
AU2927871A (fr)
AU2907471A (fr)
AU2836771A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse